Generic Name: mephobarbital
Applies to mephobarbital: oral tablet
Nervous system side effects including primarily somnolence (1% to 3%) have been reported.  Agitation, confusion, hyperkinesia, ataxia, CNS depression, nightmares, nervousness, psychiatric disturbance, hallucination, insomnia, anxiety, dizziness, and abnormal thinking have all been reported to occur in less than 1% of treated patients.  Headache has been reported with chronic use.[Ref]
Respiratory side effects including hypoventilation and apnea have been reported to occur in less than 1% of treated patients.[Ref]
Cardiovascular side effects including bradycardia, hypotension, and syncope have been reported to occur in less than 1% of treated patients.[Ref]
Gastrointestinal side effects including nausea, vomiting, and constipation have been reported to occur in less than 1% of treated patients.[Ref]
Hypersensitivity side effects including angioedema, skin rashes, and exfoliative dermatitis have been reported to occur with chronic use in less than 1% of treated patients.[Ref]
General side effects including fever have been reported to occur with chronic use in less than 1% of treated patients.[Ref]
Hepatic side effects including liver damage have been reported to occur with chronic use in less than 1% of treated patients.[Ref]
Hematologic side effects including megaloblastic anemia have been reported to occur with chronic use in less than 1% of treated patients.[Ref]
1. "Product Information. Mebaral (mephobarbital)" Sanofi Winthrop Pharmaceuticals, New York, NY. 
Not all side effects for Mebaral may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.
